Spyre Therapeutics GAAP EPS of -$0.15 beats by $0.61
Source: SeekingAlpha
2025-11-04 17:26:47 ET
More on Spyre Therapeutics
- Intelligent Development Could Make Spyre Therapeutics Best In Show
- Spyre Therapeutics prices public offering of 14.8M shares at $18.50 to raise $275M
- Spyre Therapeutics announces public offering of common stock and pre-funded warrants
- Seeking Alpha’s Quant Rating on Spyre Therapeutics
- Historical earnings data for Spyre Therapeutics
Read the full article on Seeking Alpha
For further details see:
Spyre Therapeutics GAAP EPS of -$0.15 beats by $0.61
Spyre Therapeutics Inc.
NASDAQ: SYRE
SYRE Trading
1.62% G/L:
$40.73 Last:
195,554 Volume:
$40.92 Open:
SYRE Latest News
February 23, 2026 10:38:15 am
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million
SYRE Stock Data
$2,603,991,883
65,619,664
1.61%
44
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
